Publication date: Sep 19, 2025
The adult vaccine market is undergoing rapid transformation, driven by an aging population and advancements in vaccine technology post-COVID. Research conducted in June 2022 highlights divergent stakeholder perspectives; policy makers and purchasers underestimate emerging challenges, while immunizers and consumers express concern about the increasingly complex vaccine landscape. Findings from over 750 participants reveal the need for strategic efforts to manage the integration of new vaccines and streamline communication among stakeholders. The study emphasizes improving data interoperability and adapting infrastructure, particularly through retail pharmacies, to meet rising demand. Collaborative efforts are critical to addressing bottlenecks and stakeholder overwhelm, ensuring a resilient vaccination ecosystem. This research provides actionable insights for navigating the evolving market and fostering success in a challenging era.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Interoperability | Health sciences |
| June | Medical science |
| Pharmacies | Social sciences |
| Underestimate | |
| Vaccine |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Spinosad |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | COVID 19 pandemic |
| disease | MESH | vaccine preventable diseases |
| disease | MESH | influenza |
| disease | IDO | process |
| disease | IDO | country |
| drug | DRUGBANK | Aminosalicylic Acid |
| drug | DRUGBANK | Trihexyphenidyl |
| disease | MESH | confusion |
| disease | MESH | Zoster |
| disease | MESH | nosocomial infections |
| drug | DRUGBANK | Phencyclidine |
| disease | IDO | immunodeficiency |
| disease | MESH | lifestyle |
| disease | MESH | pneumonia |
| drug | DRUGBANK | Medical air |
| drug | DRUGBANK | Methionine |
| disease | IDO | history |
| disease | IDO | pathogen |
| disease | IDO | reagent |
| disease | IDO | quality |